ELABS Elliptic Laboratories ASA
Elliptic Laboratories ASA, an artificial intelligence (AI) software company, engages in the provision of AI virtual smart sensors for the smartphone, laptop, Internet of Things, and automotive markets in Norway, the United States, China, South Korea, Taiwan, and Japan. The company offers AI Virtual Human Presence Sensor, a presence-detection solution used to improve the security of data stored on devices and to allow intuitive responses based on natural human interaction; AI Virtual Proximity Sensor that enables exquisite full-screen devices; and AI Virtual Connection Sensor that allows pair and authenticate smart devices that are in the same room using ultrasound. It also provides AI Virtual Position Sensor which automatically detects the location of an external display in relation to a laptop; AI Virtual Gesture Sensor that enables touchless user interactions; AI Virtual Breathing sensor that enables to track person's breathing; and AI Virtual heartbeat Sensor that tracks a person's heart rate. The company was incorporated in 2006 and is headquartered in Oslo, Norway.…
Industry Peers
Software - InfrastructureKey Statistics
About Elliptic Laboratories (OSL: ELABS)
›
Elliptic Laboratories (OSL: ELABS) is listed on Oslo Børs, where its shares trade in NOK. It belongs to the Software - Infrastructure industry, part of the Technology sector, and reports about 87 employees.
The shares were at 2.500 NOK on 19 November 2026, down 69.4% over 52 weeks. Its 52-week range is 2.305 NOK to 8.550 NOK: the price is 70.8% below the high and 8.5% above the low.
Its market capitalisation is 315.84M NOK.
Elliptic Laboratories reports return on equity of -74.4%, an operating margin of -82.6% and revenue down 47.5% year over year.
It holds more cash than debt, a net cash position of 45.97M NOK. Its Piotroski F-score is 4 out of 9, an average reading of its financial health. One analyst covers the stock; their mean price target of 4.800 NOK is 92.0% above the current price. The next earnings report is expected on 19 November 2026.